Human Formulations

Benfotiamine 15 mg + Methylcobalamin IP 1500 mcg + Alpha Lipoic Acid USP 100 mg + Chromium Polynicotinate 65 mcg + Folic Acid IP 1.5 mg + Inositol 10 mcg + Vitamin B6 3 mg + Calcium Pantothenate 25 mg Zinc Oxide 22.5 mg + Lutcin 5 mg (Hard Gelatin Cap)

Benfotiamine 15 mg + Methylcobalamin IP 1500 mcg + Alpha Lipoic Acid USP 100 mg + Chromium Polynicotinate 65 mcg + Folic Acid IP 1.5 mg + Inositol 10 mcg + Vitamin B6 3 mg + Calcium Pantothenate 25 mg Zinc Oxide 22.5 mg + Lutcin 5 mg (Hard Gelatin Cap) is

CapsulesNon-Beta-Lactam Capsules Single Ingredient Hard Gelatin Capsule
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Capsules, Non-Beta-Lactam Capsules
Dosage Form
Hard Gelatin Capsule
Product Type
Single Ingredient

Available strengths

Benfotiamine 15 mg + Methylcobalamin IP 1500 mcg + Alpha Lipoic Acid USP 100 mg + Chromium Polynicotinate 65 mcg + Folic Acid IP 1.5 mg + Inositol 10 mcg + Vitamin B6 3 mg + Calcium Pantothenate 25 mg Zinc Oxide 22.5 mg + Lutcin 5 mg ( Cap)

Description

Benfotiamine 15 mg + Methylcobalamin IP 1500 mcg + Alpha Lipoic Acid USP 100 mg + Chromium Polynicotinate 65 mcg + Folic Acid IP 1.5 mg + Inositol 10 mcg + Vitamin B6 3 mg + Calcium Pantothenate 25 mg Zinc Oxide 22.5 mg + Lutcin 5 mg (Hard Gelatin Cap) is a hard gelatin capsule formulated with Benfotiamine 15 mg + Methylcobalamin IP 1500 mcg + Alpha Lipoic Acid USP 100 mg + Chromium Polynicotinate 65 mcg + Folic Acid IP 1.5 mg + Inositol 10 mcg + Vitamin B6 3 mg + Calcium Pantothenate 25 mg Zinc Oxide 22.5 mg + Lutcin 5 mg ( Cap). The listed active ingredient profile is Benfotiamine; Methylcobalamin; Alpha Lipoic Acid; Chromium Polynicotinate; Folic Acid; Inositol; Vitamin B6; Calcium Pantothenate Zinc Oxide; Lutcin, placing the product in the neuropathic pain / neuro-nutritional category. The formulation contains neuropathic-pain and/or neuro-nutritional components used in selected nerve-related conditions under clinician guidance. The source identifies the dosage form as hard gelatin capsule with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured